http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 Tel Aviv, Israel - October 5, 2008 - Elron Electronic Industries Ltd. (NASDAQ & TASE: ELRN) today announced that further to its announcement on September 28, 2008 regarding Starling Advanced... http://pharmalicensing.com/redirs/news_rss//public/news/view/444724/4/elron-announces-purchases-of-starling-convertible-debentures http://pharmalicensing.com/redirs/news_rss//public/news/view/444724/4/elron-announces-purchases-of-starling-convertible-debentures South San Francisco, California, 3 October, 2008 - Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU), is pleased to announce that, as part of its ongoing fundraising activities, the Company has raised... http://pharmalicensing.com/redirs/news_rss//public/news/view/444647/4/fundraising http://pharmalicensing.com/redirs/news_rss//public/news/view/444647/4/fundraising BETHESDA, Md., October 3, 2008 -- Micromet, Inc. (Nasdaq: MITI) ("Micromet" or the "Company"), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer,... http://pharmalicensing.com/redirs/news_rss//public/news/view/444654/4/micromet-closes-40-million-private-equity-placement http://pharmalicensing.com/redirs/news_rss//public/news/view/444654/4/micromet-closes-40-million-private-equity-placement LONDON, UK, 3 October 2008 - SkyePharma PLC (LSE: SKP) ("SkyePharma" or the "Company") today announces that the new terms for the 2024 and 2025 convertible bonds are now effective which successfully... http://pharmalicensing.com/redirs/news_rss//public/news/view/444715/4/skyepharma-announces-implementation-of-revised-terms-for-convertible-bonds-and-completion-of-transactions http://pharmalicensing.com/redirs/news_rss//public/news/view/444715/4/skyepharma-announces-implementation-of-revised-terms-for-convertible-bonds-and-completion-of-transactions BETHESDA, MD - 2 October 2008 - Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO), today announced that it has entered into a Loan Agreement and Promissory Note (the "Note") with SDS... http://pharmalicensing.com/redirs/news_rss//public/news/view/444745/4/northwest-secures-us-1-0-million-debt-financing http://pharmalicensing.com/redirs/news_rss//public/news/view/444745/4/northwest-secures-us-1-0-million-debt-financing TORONTO, Sept. 29, 2008 - PreMD Inc. (TSX: PMD; PREMF.pk) today announced that it has entered into an agreement with Midsummer Investment, Ltd. with respect to an offering of approximately... http://pharmalicensing.com/redirs/news_rss//public/news/view/444753/4/premd-inc-announces-secured-debenture-financing http://pharmalicensing.com/redirs/news_rss//public/news/view/444753/4/premd-inc-announces-secured-debenture-financing September 29, 2008 -- On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December... http://pharmalicensing.com/redirs/news_rss//public/news/view/443521/4/novo-nordisk-a-s-share-repurchase-programme http://pharmalicensing.com/redirs/news_rss//public/news/view/443521/4/novo-nordisk-a-s-share-repurchase-programme Reinach, Switzerland, 29 September 2008 - Nitec Pharma AG ("Nitec Pharma" or "Nitec"), a Switzerland-based specialty pharmaceutical company focused on the development and commercialisation of... http://pharmalicensing.com/redirs/news_rss//public/news/view/443525/4/nitec-pharma-ag-secures-funding-of-chf-24m-from-tvm-capital-and-deutsche-bank http://pharmalicensing.com/redirs/news_rss//public/news/view/443525/4/nitec-pharma-ag-secures-funding-of-chf-24m-from-tvm-capital-and-deutsche-bank Halifax, Nova Scotia, September 29, 2008 - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic solutions, announced today that is has completed... http://pharmalicensing.com/redirs/news_rss//public/news/view/443541/4/medmira-announces-completion-of-equity-line-draw-down http://pharmalicensing.com/redirs/news_rss//public/news/view/443541/4/medmira-announces-completion-of-equity-line-draw-down PLEASANTON, Calif., Sept. 29, 2008 -- Thoratec Corporation (Nasdaq: THOR), a world leader in products to treat cardiovascular disease, today announced that commencing October 1, 2008, the market... http://pharmalicensing.com/redirs/news_rss//public/news/view/443618/4/thoratec-corporation-announces-conversion-rights-now-effective-on-senior-subordinated-convertible-notes http://pharmalicensing.com/redirs/news_rss//public/news/view/443618/4/thoratec-corporation-announces-conversion-rights-now-effective-on-senior-subordinated-convertible-notes